Using Amniotic Membrane for Melanocyte Transplantation in Vitiligo
Author Information
Author(s): Pedro Redondo, Ana Giménez de Azcarate, Laura Marqués, María García-Guzman, Enrique Andreu, Felipe Prósper
Primary Institution: University Clinic of Navarra, University of Navarra
Hypothesis
Can amniotic membrane serve as an effective scaffold for melanocyte transplantation in patients with stable vitiligo?
Conclusion
Transplantation of autologous melanocytes cultured on amniotic membrane is a new, simple, and effective treatment for stable vitiligo.
Supporting Evidence
- All patients showed a 90-95% repigmentation success rate after treatment.
- The largest treated area was 210 cm2, and the smallest was 4 cm2.
- Patients were followed for up to 6 months to assess treatment response.
Takeaway
Doctors took skin cells from patients with vitiligo and grew them on a special layer from the placenta, which helped the skin get its color back.
Methodology
Four patients with stable vitiligo received autologous melanocyte transplants on amniotic membrane, and their progress was monitored for up to 6 months.
Limitations
The study involved a small number of patients and lacked a control group for comparison.
Participant Demographics
1 male and 3 female patients aged 13 to 29 years with stable generalized or focal vitiligo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website